---
category: news
title: "BioXcel Therapeutics Announces European Patent Office's Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine"
excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today reported that the European Patent Office (EPO) granted the Companyâ€™s European Patent No."
publishedDateTime: 2024-03-15T12:01:00Z
originalUrl: "https://www.tmcnet.com/usubmit/2024/03/15/9978947.htm"
webUrl: "https://www.tmcnet.com/usubmit/2024/03/15/9978947.htm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "/sFGj0pKwpKHfjpcXbGRR3q5DnlPK4Gu5aS6cnITWI7aawO2D3IJX6/iufOFhKL4CIs0i5iAhbjfwWlWWhH/qh6bTOHDTLvK9HROUBuRmd1MCJY2ytFYhk7bh27vSgmFT3yU0EM1R6j2jqFhxrMhNRqkY4E0u/dFftoB+sDLl5iUY65udpGI5toSb+Zk1Zf8o2QYH3CSNsa6agTlk4G6IkiNC6fsKNlnubUuLQMjMwcAGtr7GwaqLSFZTvrYbS5UvLjI4cnSSRKKBIOc0DQpZWiVkYDT4MgpV2f9zrC2B7Na+Mz4Dr5VCbcSc2DhiJ0ANQ8vcg97zhtOWbRMsGBkGREiDpbVnV6AiD1SA0L8Qoc=;4crE2HX1w5qw9J9+iSyGfg=="
---

